| 英文名称 |
中文名称 |
CAS |
|
Rimegepant
|
|
1190363-46-2 |
|
(R)-3-METHYLPIPERAZIN-2-ONE
|
(R)-3-甲基哌嗪-2-酮 |
922178-61-8 |
|
Rimegepant
|
|
1373116-06-3 |
|
(S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)piperidine-4-carboxamide
|
|
1143534-59-1 |
|
3-Methyl-1,2,4-thiadiazole-5-carbohydrazide
|
3-甲基-1,2,4-噻二唑-2(3H)-碳酰肼 |
1375066-73-1 |
|
Zavegepant
|
|
855778-84-6 |
|
Elacestrant
|
|
722520-36-7 |
|
4-nitroso-1,3-dihydroquinoxalin-2-one
|
2(1H)-喹喔啉酮,3,4-二氢-4-亚硝基-(9CI) |
53374-52-0 |
|
Elacestrant
|
|
34841-47-9 |
|
Omaveloxolone (RTA 408)
|
|
1474034-05-3 |
|
Deucravacitinib
|
4,6-二羟基哒嗪-3-羧酸 |
1442437-21-9 |
|
(S)-tert-butyl 4-(tert-butoxycarbonylamino)-4-(1-(4-chlorophenyl)-3-hydroxypropylcarbamoyl)piperidine-1-carboxylate
|
|
1143534-57-9 |
|
Deucravacitinib
|
4,6-二氯哒嗪-3-羧酸锂水合物 |
2245111-15-1 |
|
Anserine
|
鹅肌肽 |
584-85-0 |
|
Spermidine
|
亚精胺 |
124-20-9 |
|
Deucravacitinib
|
|
1609394-10-6 |
|
Rimegepant
|
|
1373116-05-2 |
|
Deucravacitinib
|
4,6-二氯-N-(甲基-d3)-3-哒嗪甲酰胺 |
1609393-89-6 |
|
4-Chloro-p-fluorobutyrophenone
|
4-氯-4'-氟苯丁酮 |
3874-54-2 |
|
Elacestrant
|
|
32263-70-0 |
|
Infigratinib
|
|
872509-56-3 |
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-3-methyl-, (6bR,10aS)
|
|
313368-85-3 |
|
(2S)-Hydroxy(phenyl)acetic acid-(4aS,9bR)-6-bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole (1:1)
|
(2S)-2-羟基-2-苯基乙酸；(4aS,9bR)-6-溴-1H,2H,3H,4H,4aH,5H,9bH-吡啶[4,3-b]吲哚 |
1059630-13-5 |
|
4-tert-butoxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester
|
1-Boc-4-(Boc-氨基)哌啶-4-甲酸 |
189321-65-1 |
|
Deucravacitinib
|
2-甲氧基-3-硝基苯甲酸甲酯 |
90564-26-4 |
|
Macitentan
|
|
146533-41-7 |
|
phenyl N-[(E)-(5-nitrofuran-2-yl)methylideneamino]carbamate
|
|
313369-25-4 |
|
N-Carbethoxy-4-piperidone
|
N-乙氧羰基-4-哌啶酮 |
29976-53-2 |
|
Ectoine
|
依克多因 |
96702-03-3 |
|
Sodiumtetrahydrojasmonate
|
四氢茉莉酸钠 |
1175006-92-4 |
|
2(1H)-Quinoxalinone,3,4-dihydro-; 1,2,3,4-Tetrahydro-2-quinoxali
|
3,4-二氢-1H-喹噁啉-2-酮 |
59564-59-9 |
|
Deucravacitinib
|
2-甲氧基-3-硝基苯甲酰胺 |
722538-98-9 |
|
Infigratinib
|
|
872511-34-7 |
|
Infigratinib
|
|
872511-35-8 |
|
Deucravacitinib
|
环丙酰胺 |
6228-73-5 |
|
7-methoxy-2,2-dimethylchroman-6-ylpalmitate
|
二甲基色满棕榈酸酯美白剂 |
1105025-85-1 |
|
6-bromo-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride
|
|
1059630-11-3 |
|
Calcifediol
|
25-羟基维生素D3 |
19356-17-3 |
|
Zavegepant
|
|
1414976-15-0 |
|
METHYL 4-((TERT-BUTOXYCARBONYL)AMINO)PIPERIDINE-4-CARBOXYLATE
|
4-N-BOC-哌啶-4-甲酸甲酯 |
115655-44-2 |
|
(3S)-3-amino-3-(4-chlorophenyl)propanoic acid
|
(S)-3-氨基-3-(4-氯苯基)丙酸 |
131690-60-3 |
|
Elacestrant
|
|
860034-09-9 |
|
Deucravacitinib
|
|
679406-03-2 |
|
DIPALMITOYL HYDROXYPROLINE
|
二棕榈酰羟脯氨酸 |
41672-81-5 |
|
Deucravacitinib
|
|
1352925-63-3 |
|
Macitentan
|
|
706811-25-8 |
|
Elacestrant
|
|
722536-73-4 |
|
Deucravacitinib
|
3-(2-甲氧基-3-硝基苯基)-1H-1,2,4-三唑 |
1609394-05-9 |
|
Deucravacitinib
|
|
1609394-08-2 |
|
Cholesterol
|
植物源胆固醇 |
57-88-5 |
|
Fezolinetant
|
|
1429560-52-0 |
|
Lumateperone
|
|
313369-16-3 |
|
DIAMINOPYRIMIDINE OXIDE
|
二氨基嘧啶氧化物 |
|
|
(3S)-3-amino-3-(4-chlorophenyl)propan-1-ol
|
(S)-对氯-Β-苯丙氨醇 |
886061-26-3 |
|
Macitentan
|
|
1393813-43-8 |
|
Infigratinib
|
|
115619-01-7 |
|
(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate
|
(6bR,10aS)-3-甲基-2,3,6b,7,10,10a-六氢-1H-吡啶并[3',4':4,5]吡咯并[1,2,3-de]喹喔啉-8(9H)-羧酸叔丁酯 |
313369-26-5 |
|
Fisetin
|
漆黄素 |
528-48-3 |
|
Ergothioneine
|
麦角硫因 |
497-30-3 |
|
Deucravacitinib
|
|
649729-45-3 |
|
Elacestrant
|
|
59557-92-5 |
|
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine
|
6-氯-7-氮杂嘌呤 |
3680-69-1 |
|
Zavegepant
|
|
868707-31-7 |
|
Elacestrant
|
|
722520-42-5 |
|
(3R)-4-[(2,4-dimethoxyphenyl)methyl]-3-methylpiperazin-2-one
|
(R)-3-甲基-4-(2,4-二甲氧基苄基)哌嗪-2-酮 |
1383146-20-0 |
|
Macitentan
|
|
1393813-42-7 |
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,9,10-tetrahydro-2-oxo-, ethyl ester
|
2-氧代-2,3,9,10-四氢-1H-吡啶[3',4':4,5]吡咯并[1,2,3-DE]喹喔啉-8(7H)-羧酸乙酯 |
313544-31-9 |
|
Deucravacitinib
|
|
1609394-23-1 |
